The role of cytochrome P-450 in salt-sensitive stroke in stroke-prone spontaneously hypertensive rats

Hypertension Research

Volumn 31, Issue 9, 2008, Pages 1821-1827

  Ying, Chen Jiang ^a,b   Noguchi, Takanori ^c   Aso, Hiroaki ^a   Ikeda, Katsumi ^d   Yamori, Yukio ^d   Nara, Yasuo ^a  

^a SHUJITSU UNIVERSITY   (Japan)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c FUKUOKA WOMEN'S UNIVERSITY   (Japan)

^d MUKOGAWA WOMEN'S UNIVERSITY   (Japan)

Author keywords

Cerebral blood flow; Cytochrome P 450 ; Peroxisome proliferator activated receptor ; Salt sensitive; Stroke prone sponteaneously rat

Indexed keywords

CLOFIBRATE; CYTOCHROME P450; CYTOCHROME P450 2C11; CYTOCHROME P450 2C23; CYTOCHROME P450 4A1; OXIDOREDUCTASE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL DIAMETER; BRAIN BLOOD FLOW; BRAIN CORTEX; CONTROLLED STUDY; DOPPLER FLOWMETRY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME REGULATION; HYPERTENSION; MALE; MICROSCOPY; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; RAT; SALT LOADING; STROKE; STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT; SURVIVAL TIME; WESTERN BLOTTING;

EID: 55449092311     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.31.1821     Document Type: Article

References (26)

1. Rubattu S, Volpe M, Kreutz R, Ganten U, Ganten D, Lindpaintner K: Chromosomal mapping of quantitative trait loci contributing to stroke in a rat model of complex human disease. Nat Genet 1996; 13: 429-434.
2. Deplanque D, Gele P, Petrault O, et al: Peroxisome proliferator-activated receptor-alpha activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment. J Neurosci 2003; 23: 6264-6271.
3. Inoue H, Jiang XF, Katayama T, Osada S, Umesono K, Namura S: Brain protection by resveratrol and fenofibrate against stroke requires peroxisome proliferator-activated receptor alpha in mice. Neurosci Lett 2003; 352: 203-206.
4. Ishizuka T, Ito O, Tan L, et al: Regulation of chytochrome P-450 4A activity by peroxisome proliferator-activated receptors in rat kidney. Hypertens Res 2003; 26: 929-936.
5. Fleming I: Cytochrome P450 and vascular homeostasis. Circ Res 2001; 89: 753-762.
6. Hoagland KM, Maier KG, Roman RJ: Conributions of 20-HETE to the antihypertensive effects of Tempol in Dahl salt-sensitive rats. Hypertension 2003; 41: 697-702.
7. Muller DN, Theuer J, Shagdarsuren E, et al: A peroxisome proliferator-activated receptor-alpha activator induces renal CYP2C23 activity and protects from angiotensin II-induced renal injury. Am J Pathol 2004; 164: 521-532.
8. Alkayed NJ, Birks EK, Narayanan J, Petrie KA, Kohler-Cabot AE, Harder DR: Role of P-450 arachidonic acid epoxygenase in the response of cerebral blood flow to glutamate in rats. Stroke 1997; 28: 1066-1072.
9. The Physiological Society of Japan: Guiding principles for the care and use of animals in the field of physiological sciences. J Physiol Soc Jpn 1998; 60: vii-viii.
10. Ikeda K, Nara Y, Yamori Y: Indirect systolic and mean blood pressure determination by a new tail cuff method in spontaneously hypertensive rats. Lab Anim 1991; 25: 26-29.
11. Krapfenbauer K, Berger M, Lubec G, Fountoulakis M: Changes in the brain protein levels following administration of kainic acid. Electrophoresis 2001; 22: 2086-2091.
12. Ying CJ, Xu JW, Ikeda K, Takahashi K, Nara Y, Yamori Y: Tea polyphenols regulate nicotinamide adenine dinucleotide phosphate oxidase subunit expression and ameliorate angiotensin II-induced hyperpermeability in endothelial cells. Hypertens Res 2003; 26: 823-828.
13. Morii S, Ngai AC, Winn HR: Reactivity of rat pial arterioles and venules to adenosine and carbon oxide: with detailed description of the closed cranial window technique in rat. J Cereb Blood Flow Metab 1986; 6: 34-41.
14. Noguchi T, Ikeda K, Sasaki Y, et al: Effects of vitamin E and sesamin on hypertension and cerebral thrombogenesis in stroke-prone spontaneously hypertensive rats. Hypertens Res 2001; 24: 735-742.
15. Ley K, Pries AR, Gaehtgens P: Topological structure of rat mesenteric microvessels networks. Microvasc Res 1986; 32: 315-332.
16. Morita-Tsuzuki Y, Bouskela E, Hardebo JE: Vasomotion in the rat cerebral microcirculation recorded by laser-Doppler flowmetry. Acta Physiol Scand 1992; 146: 431-439.
17. Gustavsson M, Mallard C, Vannucci SJ, Wilson MA, Johnston MV, Hagberg H: Vascular response to hypoxic preconditioning in the immature brain. J Cereb Blood Flow Metab 2007; 27: 928-938.
18. Moffat MP, Ward CA, Bend JR, Mock T, Farhangkhoee P, Karmazyn M: Effects of epoxyeicosatrienoic acids on isolated hearts and ventricular myocytes. Am J Physiol 1993; 264: H1154-H1160.
19. Alkayed NJ, Birks EK, Hudetz AG, Roman RJ, Henderson L, Harder DR: Inhibition of brain P-450 arachidonic acid epoxygenase decreases baseline cerebral blood flow. Am J Physiol 1996; 271: 1541-1546.
20. Alkayed NJ, Goyagi T, Joh HD, et al: Neuroprotection and P450 2C11 upregulation after experimental transient ischemic attack. Stroke 2002; 33: 1677-1684.
21. Yamori Y, Horie R: Developmental course of hypertension and regional cerebral blood flow in stroke-prone spontaneously hypertensive rats. Stroke 1977; 8: 456-461.
22. Mies G, Hermann D, Ganten U, Hossman KA: Hemodynamics and metabolism in stroke-prone spontaneously hypertensive rats before manifestation of brain infarcts. J Cereb Blood Flow Metab 1999; 19: 1238-1246.
23. Ellis EF, Police RJ, Yancey L, McKinney JS, Amruthes SC: Dilation of cerebral arterioles by cytochrome P-450 metabolites of arachidonic acid. Am J Physiol Heart Circ Physiol 1990; 259: 1171-1177.
24. Zhao X, Quigley JE, Yuan J, Wang MH, Zhou Y, Imig JD: PPAR-alpha activator fenofibrate increases renal CYP-derived eicosanoid synthesis and improves endothelial dilator function in obese Zucker rats. Am J Physiol Heart Circ Physiol 2006; 290: H2187-H2195.
25. Bordet R, Ouk T, Petrault O, et al: PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases. Biochem Soc Trans 2006; 34: 1341-1346.
26. Atkins D, Psaty BM, Koepsell TD, Longstreth WT Jr, Larson EB: Cholesterol reduction and the risk for stroke in men. A meta-analysis of randomized, controlled trials. Ann Intern Med 1993; 119: 136-145.